ERAS (Erasca) SpecialCharges


ERAS Erasca Inc ERAS
22 GF Score
Price $18.29
! 3 Warning Signs
View Full Analysis

What is Erasca SpecialCharges?

Special Charges only applies to banks.

ERAS
22GF Score
Erasca Inc ERAS
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Erasca Business Description

Address 3115 Merryfield Row, Suite 300, San Diego, CA, USA, 92121
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
22GF Score

Get the complete analysis for ERAS

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.29
Price